Skip to main content
B

Bioprognos

The startup provides non-invasive testing services for the early detection and management of cancer through the analysis of multiple biomarkers in body fluids. By utilizing disease activity algorithms for qualitative detection, the company enables patients and healthcare providers to obtain critical information from a simple blood test.

Barcelona, SpainFounded 20163200+ followers
Updated 3 months ago

Funding

$410K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Features

  • The startup provides non-invasive testing services for the early detection and management of cancer through the analysis of multiple biomarkers in body fluids. By utilizing disease activity algorithms for qualitative detection, the company enables patients and healthcare providers to obtain critical information from a simple blood test.
This profile is AI-generated and may contain inaccuracies.